Sign up for our eNewsletters
Get the latest news and updates
ProBioGen
ProBioGen bioreactor
The agreement covers cell line development, process development, and GMP manufacturing for a lead Fc-fusion candidate targeting Type 1 diabetes.
Jan. 6, 2026
Shutterstock
Automated pharmaceutical production line
The acquisition adds to Title21’s digital capabilities for healthcare and life sciences organizations across the cell and gene therapy ecosystem.
Jan. 6, 2026
Shutterstock
Multi exposure of DNA hologram on abstract background with two men handshake. Concept of bioengineering
Skye has licensed Halozyme’s drug delivery technology to enable evaluation of higher-dose subcutaneous administration of an investigational antibody.
Jan. 5, 2026
Shutterstock
Green sustainable supply chain technology concept
The certification reflects the company-wide integration of sustainability into supplier management and follows the CRDMO’s continued expansion of its manufacturing network.
Jan. 5, 2026

Learning Resources

dreamstime_xxl_249582173
dreamstime_xxl_249582173
Sponsored
Innovators are redefining bioreactor technology, cell and gene therapy manufacturing, pharmaceutical packaging, and small molecule APIs. Pharma Manufacturing’s 2025 Innovation...
Dec. 8, 2025
cover_gettyimages1320311776
cover_gettyimages1320311776
Sponsored
Faced with increasing quality, risk, and talent pressures, pharma manufacturers are embracing smart manufacturing and automation to overcome these challenges. Find out in this...
Nov. 20, 2025
dreamstime_m_45052120
dreamstime_m_45052120
Sponsored
Advancements in cleanroom technology are redefining pharmaceutical manufacturing with energy-efficient HVAC, sustainable materials, and intelligent airflow. However, much more...
Oct. 28, 2025
animal_health_brochure
Sponsored
Explore proven alternatives to fetal bovine serum (FBS). Discover how donor bovine serum and other options can reduce cost and supply risks while maintaining performance in bioproductio...
Oct. 21, 2025

Podcast

editreview
Large pharmaceutical companies have promised to invest more than $370 billion over the next five years in the U.S., driven by Trump’s threat of pharma-specific tariffs.
Dec. 19, 2025
editreview
The deal is a win for Britain’s beleaguered pharma sector and comes after President Trump threatened to impose 100% tariffs on branded drugs imported to the U.S.
Dec. 5, 2025
editreview
This week, the industry saw a flurry of pharma manufacturing investment announcements as companies continue to onshore production in the United States.
Nov. 21, 2025
editreview
Eli Lilly and Novo Nordisk are latest to accept quid pro quo of Most Favored Nation drug pricing and onshoring of pharmaceutical manufacturing for tariff exemptions.
Nov. 14, 2025
raleigh_skyline
Raleigh-Cary and Durham-Chapel Hill secured the first and third spots, respectively, as the nation’s most competitive markets for the production of therapeutic biologics.
Nov. 10, 2025
symphonxfinal
SymphonX, which runs all downstream unit operations in both fed-batch and continuous processes, will serve customers at Fujifilm’s Billingham manufacturing facility.
Nov. 6, 2025
elevatebiofinal
With $1.3 billion in funding, the company has established a cGMP manufacturing facility in Waltham, Massachusetts, with a second site under construction in Pittsburgh.
Nov. 5, 2025
motm_cgt_manufacturingfinal
Panelists at the 2025 Cell & Gene Meeting on the Mesa laid out the challenges and opportunities facing the industry as it looks to produce these therapies at scale.
Oct. 7, 2025
hikmagroundbreaking
Report finds 40 states and Puerto Rico are offering sales and tax exemptions to lower costs for new biomanufacturing and research and development facilities.
Dec. 4, 2025
PlantForm
2171_plantform_104_high_res
Advances in glycosylation control, plant engineering, and rapid-expression systems are redefining what’s possible for plant-made drugs and vaccines.
Nov. 13, 2025
fdawhiteoakbuilding
The agency is reviewing clinical trials that involve sending U.S. patients’ living cells to China and other “hostile countries” for genetic engineering and return infusion.
Sept. 22, 2025
dreamstime_xxl_38596122
dreamstime_xxl_38596122
Sponsored
With manufacturers under increasing pressure to reduce costs, enhance compliance, and accelerate production timelines for high quality drugs, they are increasing their investments...
Aug. 25, 2025
resilience2
Software platforms can seamlessly integrate with emerging technologies to unlock efficiencies, strengthen sustainability and enable proactive prevention of disruptions.
Sept. 10, 2025
2_1200xundefined
Sponsored
Pharmaceutical manufacturing operates in a high-stakes environment where regulatory compliance, product integrity, and operational uptime are non-negotiable. As the industry becomes...
March 5, 2025
cdmo_trends_brief_image_1540x800
Sponsored
Discover the latest contract manufacturing key trends for the life science industry, including compliance, digital transformation and more. Don't let your organization fall behind...
Feb. 24, 2025
key_to1
Sponsored
As the life sciences sector evolves with personalized medicine, biologics, and digitalization, manufacturers must innovate, invest in advanced tech, and adopt agile manufacturing...
Jan. 30, 2025
trump
In exchange for discounts to list prices on select medicines, the companies will receive relief from potential pharmaceutical tariffs over a three-year period.
Dec. 22, 2025
fdawhiteoakbuilding
The agency cited “significant violations” of current Good Manufacturing Practice regulations for finished pharmaceuticals at Novo Nordisk’s Bloomington facility.
Dec. 18, 2025
sun_pharmafinal
The pharmaceutical company is investing in a greenfield project as it looks to resolve ongoing FDA compliance issues at three existing Indian facilities.
Dec. 3, 2025
us_brit_trumpfinal
In a pharma trade deal between President Trump and British Prime Minister Starmer, the U.K.’s National Health Service will pay 25% more for innovative medicines.
Dec. 2, 2025
shipcontainersheroimage
The industry requires local resilience and flexibility in a complex global landscape, according to separate reports from consulting firms Deloitte and West Monroe.
Dec. 11, 2025
aipicfinal
The adoption of artificial intelligence has evolved with investment shifting from monitoring to predictive intelligence, according to the 2025 LogiPharma AI Report.
Nov. 17, 2025
cytiva_biopharma
Cytiva’s 2025 Global Biopharma Index shows widening gaps across regions as talent shortages, regulatory strain, and uneven sustainability progress weigh on growth.
Oct. 27, 2025
globe
According to US Pharmacopeia, 58% of KSMs used for U.S.-approved active pharmaceutical ingredients are sole sourced from a single country.
Oct. 20, 2025